Cargando…
TMEM211 Promotes Tumor Progression and Metastasis in Colon Cancer
Colon cancer is the third most important cancer type, leading to a remarkable number of deaths, indicating the necessity of new biomarkers and therapeutic targets for colon cancer patients. Several transmembrane proteins (TMEMs) are associated with tumor progression and cancer malignancy. However, t...
Autores principales: | Chang, Yung-Fu, Wang, Hsing-Hsang, Shu, Chih-Wen, Tsai, Wei-Lun, Lee, Cheng-Hsin, Chen, Chun-Lin, Liu, Pei-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297151/ https://www.ncbi.nlm.nih.gov/pubmed/37367036 http://dx.doi.org/10.3390/cimb45060287 |
Ejemplares similares
-
Antibody-recognizing residues 188-211 of TMEM106B exhibit immunohistochemical reactivity with the TMEM106B C-terminal fragment
por: Ishikawa, Ruoyi, et al.
Publicado: (2023) -
Upregulation of TMEM40 is associated with the malignant behavior and promotes tumor progression in cervical cancer
por: Zhang, Zhen-Fei, et al.
Publicado: (2023) -
TMEM106A transcriptionally regulated by promoter methylation is involved in invasion and metastasis of hepatocellular carcinoma: TMEM106A is involved in invasion and metastasis of HCC
por: Shi, Shiming, et al.
Publicado: (2022) -
The MAP3K7-mTOR Axis Promotes the Proliferation and Malignancy of Hepatocellular Carcinoma Cells
por: Cheng, Jin-Shiung, et al.
Publicado: (2019) -
Upregulation of TMEM45A Promoted the Progression of Clear Cell Renal Cell Carcinoma in vitro
por: Jiang, Huiming, et al.
Publicado: (2021)